SFDA Approves Antofloxacin

China's pharmaceutical research sector has reached another milestone. Antofloxacin is the first locally-developed fluoroquinolone to receive patent protection. It is BMI's view that the Asian country will develop many more novel compounds over the next decade.

To read the full article, please choose one of the following options: